ABOUT US
Cytiva provides the expertise and tools spanning a wide range of applications from basic research of proteins and cells to large-scale purification of biopharmaceuticals. Within the bioprocessing space, Cytiva provides products and expertise for developers and manufacturers of biotherapeutics to enable efficient, flexible and cost-effective approaches to characterization, expression and purification of biomolecules. The company offers tools and support to take recombinant proteins, monoclonal antibodies, plasma proteins, oligonucleotides and vaccines from research, through process development, to full-scale manufacturing. Cytiva has a "healthymagination" vision for the future to improve quality, decrease costs and increase access to better healthcare around the world.
Bioprocessing: cell culture, chromatography and filtration solutions, and analytics
Cytiva's portfolio encompasses both upstream and downstream processing and includes solutions for large-scale production as well as tools for process development, Quality by Design, analytical analysis and flexible manufacturing. Some key product areas are listed below:
- ReadyToProcess™ - a platform of ready to use, and single use, flexible-manufacturing equipment, includes WAVE Bioreactor™ systems and Cellbag™ single-use cell culture bioreactors.
- Xcellerex™ - a single-use technologies platform including XDR bioreactors, XDM Quad Mixers, and related single-use assemblies
- PreDictor™ 96-well plates and PreDictor RoboColumn™ units for process development of chromatography separations
- ULTA™ filters for sterile filtration and clarification applications
- MabSelect SuRe™ LX, the Capto™ media family; and Capto ImpRes all modern BioProcess™ media for all phases of purification
- ÄKTA™ systems for all scales of chromatography and filtration
- AxiChrom™ chromatography columns
- Technical support, and training through Fast Trak services
Cytiva's products enable improvements in process efficiency through optimized performance, advanced automation, integrated unit operations, and technical support. These solutions allow agile manufacturing with shortened development times and excellent facility utilization. The company offers complete start-to-finish solutions in a range of areas such as monoclonal antibodies, plasma proteins, oligonucleotides and vaccines, and is continuously developing its range of products and services.
Additionally, Cytiva has a range of products for characterization and analysis of biomolecular interactions and biomolecule stability, including Biacore™ SPR and MicroCal™ DSC systems.
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
- Regulatory Convergence With Aurion Biotech
- Running Interference: RNAi With Silence Therapeutics' Craig Tooman
- Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
- Optimize Antibody Fragment Purification
- Optimization Of A Two-Step Purification Method For Bispecific Antibodies
- Gene Tx For Renal Disease With Purespring CEO Richard Francis
- High Quality Resins Manufacturing During A Pandemic And Beyond
- A Panel Discussion: Improving Biomanufacturing Resilience In An Uncertain Future
- Demonstrating ROI For Increased Digital Plant Maturity
- Fighting Blindness & Funding The Fight With Opus Genetics' Ben Yerxa, CEO
- Supporting The Global Biopharma Industry With Single-Use Capacity Expansion
- Gynecological Cancer Therapies With Context Therapeutics' Martin Lehr
- Strategies For Scaling Up mRNA Manufacturing
- Commensal Viral Vectors With Ring Therapeutics' Tuyen Ong, M.D.
- Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.
- mRNA Manufacturing: In House Or Outsourced?
- Regulatory Concerns In mRNA Therapeutic Development
- CMC Considerations For mRNA Manufacturing
- A Q&A On CMC In mRNA Manufacturing
- SparingVision's Stéphane Boissel On Insourcing Bio Talent & IP
- Biotech M&A Trends With Allan Shaw
- Outsourcing Process Dev: Key Considerations For Biopharma
- The Market For mRNA Vaccines & Therapeutics
- Three Leaders In mRNA Therapeutics
- Process Development Challenges In mRNA Therapeutics
- Addressing mRNA’s Scalability And Supply Challenges
- LNP Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.
- Find The Right Intensification Strategy For Upstream, Downstream Processes
- Strategies, Emerging Technologies For mAb Capture
- CAR T-Cells Therapies Get Closer To Solid Tumor Application
- AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D
- Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago
- Biacore™ SPR System Fact Or Fiction Series
- Is The Sensitivity Of Optical Biosensors Important?
- Can Kinetics Provide Detailed Information About Binding Interactions?
- Is Evaporation Important For Optical Biosensors?
- Can You Run Crude Samples Using An SPR Instrument?
- High-Throughput mAb Purification With Fibro Chromatography
- The Next Pandemic: Biopharma's Opportunities and Obligations
- BioProcess Automation ROI And Next Steps
- The Incremental Approach To BioProcess Automation Adoption
- Technical Implications, Cost Considerations Of BioProcess Automation
- Who Champions Process Automation, And Who Runs It?
- What Motivates A Process Automation Investment?
- BioProcess Automation: Three Leaders On Where They Stand
- Plant-Based Biologics With iBio's Randy Maddux
- NK Cell Therapy Accessibility Ft. Dr. Kleanthis Xanthopoulos
- A Hybrid mAb Manufacturing Model With John Glasspool
- In-House Manufacturing: Key To Driving A Diabetes Vaccine?
- Biotech Capital Markets Forecast With Allan Shaw
- Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias
- Genomic Medicine And The Tools To Realize Its Potential
- Behind the Scenes: Downstream Hardware Equipment Manufacturing In Umeå
- Cytiva Attains Business Continuity Management System ISO Certification
- Bye Bye Broad Spectrum: A Precision Approach To Infectious Disease
- Bioenginnering Human Tissue With Humacyte's Dr. Heather Prichard
- Top Stories Of 2021 With Allan Shaw
- Complete CAR T Manufacturing Control with Cellectis' Steve Doares
- Elevation Oncology's Dr. Shawn Leland On Genomically-Guided Medicine
- Kite Pharma's Ultimate Supply Chain Test - A Q&A With Their 4-Exec Panel On Overcoming The Pandemic's Disruption
- Enabling Bioprocess Control With Successful Automation Strategies
- Inhalable mAbs And Vaccines With TFF's Glenn Mattes
- Democratizing Biologics With Brian Finrow, J.D., And Craig Behnke, Ph.D.
- Cornering The Antibody Market: Akesobio CEO Dr. Michelle Xia, Ph.D.
- Boost Performance With A Chromatography Resin Update
- Mechanistic Modeling: Digital Twins Are Here To Stay
- Turning The Liver Into A mAb Factory: Homology's Arthur Tzianabos, Ph.D.
- Maximizing mRNA With Precision Nanosystems' James Taylor, Ph.D.
- Sarepta's Brian Winstead: Foundations Of Flexible Manufacturing
- Beating The CDMO Capacity Crunch
- Capture Of Histidine-Tagged Molecules Using Biacore His Capture Kit
- 3 Tips For Purifying His-Tagged Proteins
- The Clinical Trials Conundrum With Allan Shaw
- AltruBio's Gene Lee, Ph.D. On CMC Developability Assessments
- The Importance Of CMC Developability Assessments: A Conversation With AltruBio’s Dr. Gene Lee
- AVROBIO’s Geoff MacKay On Cell & Gene Scalability
- bluebird Bio's Scott Cleve On New Therapies, New Regulatory Approaches
- Apply For A Breakthrough Therapy Designation (And Win It!)
- The Importance Of CDMO Capacity For Viral Vectors: A Conversation With Forge’s Dr. Timothy Miller
- CDMO With A Pipeline Featuring Forge Biologics President & CEO Dr. Timothy J. Miller
- Bioprocess Automation: Truth Or Illusion?
- Building A DNA Delivery System With Poseida Tx CEO Eric Ostertag, M.D., Ph.D.
- Best Practices For Outsourcing Process Development
- Increasing mRNA Capabilities, Capacity
- From Bayer To Startup Bio With AltruBio's Dr. Judy Chou
- Increase Drug Discovery Productivity, Optimize SPR Data Interpretation
- Creating Competitive Differentiation With Allan Shaw
- Key Insights Into Overcoming mRNA Process Challenges
- Factors Which Impact mAb Process Scale-Up
- Gene Therapy Manufacturing Advances With Aruvant CTO Dr. Palani Palaniappan
- Design Agile Manufacturing With An Integrated Drug Product Ecosystem
- iNK T-Cell Immuno-oncology For Solid Tumors With Dr. Ian Walters
- Digital Transformation In Cell Therapy
- Cold Chain Logistics For Cell Therapy Production – A Conversation With Celyad’s Thomas Lequertier
- How To Apply For BTD And Win It With Drs. Ira Gupta & Shanthi Ganeshan
- Building An Army: Cell Therapy Platforms With Dr. Helen Sabzevari, CEO Of Precigen
- Implementing GMP For Early-Phase Development With Cartesian Therapeutics Co-Founder And CEO, Dr. Murat Kalayoglu
- Cold Chain Integrity & Sustainability With Celyad Oncology's Thomas Lequertier
- Peptides & Proteins: Resetting The Immune System With Revolo CEO Jonathan Rigby
- The Cell & Gene Talent Crunch: Attracting Top-Notch Employees In A Competitive Landscape
- Intranasal Prophylactics For Flu & Coronavirus With Leyden Labs' Koenraad Wiedhaup
- Talking SPAC With Allan Shaw
- A Vaccine For Type 1 Diabetes With Diamyd Medical's Dr. Ulf Hannelius
- CAR T Process Automation With Kite Pharma's Charles Calderaro III
- Biopharma PR 101 with Matt Middleman, M.D.
- Forecasting The Integrity Of The Biopharma Supply Chain
- A Scale-Up Story With Solis BioDyne Drs. Kadri Artma and Angela Vaasa
- Transforming Your Biopharma Automation Capabilities
- Academia + Industry with BridgeBio's Dr. Michael Henderson
- GSK's Michael Mehler On The Cell & Gene Talent Crunch
- RNA-Engineered Cell Therapy With Cartesian's Dr. Murat Kalayoglu
- mRNA Manufacturing Workflow
- 3 Steps To Optimize The Fed-Batch Process For mAb Production
- Real-Time Clinical Analysis with Glympse Bio's Dr. Caroline Loew
- AAV & Lentiviral Gene Therapies with Sio's Dr. Pavan Cheruvu
- Fundamentals Of Size Exclusion Chromatography
- Explore Protein Function Using Surface Plasmon Resonance (SPR)
- Purifying Infectious Virus Particles Using ÄKTA™ Start
- Tips For Purifying Cryo-EM Samples
- Pandemic Demand Forces Rapidly Increased Production And Expertise
- Med Device Meets Biopharma with OncoSec's Dan O'Connor, J.D.
- Introduce N-1 Perfusion To Intensify The Seed Train At Higher Starting Density
- Intensified, Improved Fed-Batch Production Process
- Drug Development: From Bench To Bedside With Allan Shaw
- Clinical Strategy For Successful Cell And Gene Therapy — How Did I Get Here?
- Strategies For Startups — How To Structure Milestones For Successful Outcomes
- Attracting The Right Capital — Forming Partnerships For Long-Term Success
- Digital Transformation In Cell Therapy with Organicell Drs. Mari Mitrani & Michael Bellio
- Biopharma Regulatory Requirements With bluebird bio's Scott Cleve
- Filling A Vaccine Void with Cue Biopharma's Dan Passeri, J.D.
- Viral Vector Scale-Up: How Can We Bridge The Technology Gaps?
- Supercharging An ADC Program With SOTIO CEO Dr. Radek Špíšek
- How To Attract Investors – Funding Advice For Biotechs From VC Experts
- mAb Manufacturing with Rezolute Bio's Nevan Charles Elam, J.D.
- Accelerating cGMP Production Using Rapid Tech Transfer
- Reducing CMC Risk From IND To Commercial Manufacturing Of Cell And Gene Therapies
- Bench To Bedside And FDA Submission Strategies For Cell And Gene Therapies
- Cell Therapy Platform Dev With Precigen CEO Dr. Helen Sabzevari
- Advancements In Antibody Purification
- Bayer Evaluates Fibro For Scalable Single-Use mAb Purification
- A CFO's Prescription For Biopharma Success
- A Biopharma Pivot Story With Compugen's Dr. Anat Cohen-Dayag
- Improve Bioprocessing Efficiency With A Standardized Automation Platform
- Integrated Manufacturing: Chromatography Meets Predesigned DeltaV
- Preparing For The Clinic With Amolyt Pharma's Dr. Thierry Abribat
- Achieving Business Continuity In Pharma During COVID-19 Restrictions
- Pioneering Antiviral Conjugates With Cidara's Dr. Jeff Stein
- AI & The Human Genome With Dr. Dietrich Stephan
- The FDA's Progressive Appeal ft. Allan Shaw
- 02.10.21 -- Securing Today's Biomanufacturing Supply Chain
This website uses cookies to ensure you get the best experience on our website. Learn more